Literature DB >> 12660003

Smoking status, occupational asbestos exposure and bronchial location of lung cancer.

Christophe Paris1, Jacques Benichou, Florence Saunier, Josette Metayer, Patrick Brochard, Luc Thiberville, Georges Nouvet.   

Abstract

The objective of this study was to determine the factors associated with central airway versus peripheral bronchial location of lung cancer. All patients diagnosed with lung cancer from 1997 through 2000 in the Respiratory Disease Department of Rouen University Hospital were prospectively interviewed about their smoking and occupational history using a standardized questionnaire. All patients underwent white-light bronchial endoscopy using a 4.5 mm flexible endoscope. Tumors were classified as central when they were accessible and visible using this technique. Out of 217 cases of lung cancer included in this study, 155 (71%) were central. Histological type of lung cancer was strongly associated with bronchial location as central location was observed in 48, 82 and 92% of Adenocarcinoma (AC), Squamous Cell (SqC), and Small Cell Carcinoma (SCC), respectively (P<0.0001). Among non asbestos-exposed patients, location varied little with smoking status, with central location frequency ranging from 74 to 80%. In contrast, lung cancer was recorded central in 41% of long-term (> or =10 years) ex-smokers, 67% of short-term (<10 years) ex-smokers and 75% of current smokers (P=0.04) among patients exposed to asbestos, suggesting an interaction between duration of smoking cessation and occupational asbestos exposure with respect to lung cancer location. These findings were confirmed after adjustment for sex, age and histologic type in multivariate analysis. These results suggest that individually-tailored multimodality screening strategies relying on various combinations of low-dose CT scan, sputum analysis and fluorescence endoscopy according to each patient's profile may be more effective than standard strategies based on a single approach for all patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660003     DOI: 10.1016/s0169-5002(02)00538-x

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  6 in total

1.  The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients.

Authors:  Bing-Yen Wang; Jing-Yang Huang; Heng-Chung Chen; Ching-Hsiung Lin; Sheng-Hao Lin; Wei-Heng Hung; Ya-Fu Cheng
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-08       Impact factor: 4.553

Review 2.  Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research.

Authors:  Jessica L Burris; Jamie L Studts; Antonio P DeRosa; Jamie S Ostroff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-17       Impact factor: 4.254

3.  Association between clinical outcomes and local treatment in stage IV non-small cell lung cancer patients with single extrathoracic metastasis.

Authors:  Jeong Uk Lim; Hye Seon Kang; Ah Young Shin; Chang Dong Yeo; Chan Kwon Park; Sang Haak Lee; Seung Joon Kim
Journal:  Thorac Cancer       Date:  2022-03-31       Impact factor: 3.223

4.  ROS-mediated genotoxicity of asbestos-cement in mammalian lung cells in vitro.

Authors:  Elke Dopp; Santosh Yadav; Furquan Ahmad Ansari; Kunal Bhattacharya; Ursula von Recklinghausen; Ursula Rauen; Klaus Rödelsperger; Behnaz Shokouhi; Stefan Geh; Qamar Rahman
Journal:  Part Fibre Toxicol       Date:  2005-10-06       Impact factor: 9.400

5.  Residence in Proximity of a Coal-Oil-Fired Thermal Power Plant and Risk of Lung and Bladder Cancer in North-Eastern Italy. A Population-Based Study: 1995-2009.

Authors:  Paolo Collarile; Ettore Bidoli; Fabio Barbone; Loris Zanier; Stefania Del Zotto; Simonetta Fuser; Fulvio Stel; Chiara Panato; Irene Gallai; Diego Serraino
Journal:  Int J Environ Res Public Health       Date:  2017-07-31       Impact factor: 3.390

6.  Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients.

Authors:  Jeong Uk Lim; Chang Dong Yeo; Chin Kook Rhee; Yong Hyun Kim; Chan Kwon Park; Ju Sang Kim; Jin Woo Kim; Seung Joon Kim; Hyoung Kyu Yoon; Sang Haak Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.